Kowa Company, Ltd.
Privately held: no public share price
Assets
(3 total)
3Total Assets
0Approved
2Phase 3 / Filed
1Phase 1–2 / Early
5Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
Anagliptin(Suiny) | Phase 3 | DPP-4Small molecule | Type 2 Diabetes |
Pemafibrate(Parmodia) | Phase 3 | PPAR-alphaSmall molecule | Atherosclerotic Cardiovascular DiseaseSevere HypertriglyceridemiaCardiovascular Disease / DyslipidemiaCholestatic Liver Disease Hypertriglyceridemia, Primary Biliary Cholangitis |
Tofogliflozin(Apleway / Deberza) | Phase 2 | SGLT2Small molecule | Type 2 Diabetes |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.